FGAM
TWST icon

Financial Gravity Asset Management’s Twist Bioscience TWST Stock Holding History

Financial Gravity Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2
Closed -$77 – 1767
2024
Q1 		$77 Hold
2
– – ﹤0.01% 997
2023
Q4 		$75 Buy
+2
New +$46 ﹤0.01% 1101
2021
Q3 		– Hold
0
– – – 340

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Financial Gravity Asset Management's TWST Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of Twist Bioscience (TWST) in Q2 2024, closing a stake of 2 shares — an estimated $77 sold.

Financial Gravity Asset Management first reported a position in TWST in Q4 2023 and held it in 2 quarters. The position peaked at $77 in Q1 2024. 263 funds tracked by Wall St. Rank hold TWST as of Q2 2024.

  • Financial Gravity Asset Management reported no remaining Twist Bioscience position as of Q2 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 2 Twist Bioscience shares in Q2 2024, an estimated $77.
  • Financial Gravity Asset Management first reported a position in Twist Bioscience in Q4 2023 and held it in 2 quarters.
  • Financial Gravity Asset Management's Twist Bioscience position peaked at $77 in Q1 2024.
  • 263 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.